These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24656034)

  • 1. Acute antibody-mediated rejection possibly due to anti-human leukocyte antigen DQB1 antibodies after renal transplantation - case report.
    Yamanaga S; Watarai Y; Takeda A; Yamamoto T; Hiramitsu T; Tsujita M; Goto N; Uchida K; Katayama A; Morozumi K; Kobayashi T
    Transplant Proc; 2014; 46(2):640-3. PubMed ID: 24656034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of accelerated acute rejection after ABO-compatible living unrelated kidney transplantation.
    Matsuo N; Yamamoto H; Kobayashi A; Yamamoto I; Mitome J; Maruyama Y; Hayakawa H; Miyazaki Y; Utsunomiya Y; Hosoya T; Yamaguchi Y
    Clin Transplant; 2009 Aug; 23 Suppl 20():23-6. PubMed ID: 19594591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment of Antibody-Mediated Rejection by De Novo Donor Specific Antibody After Primary Renal Transplantation in a Recipient From a Cadaveric Donor: A Case Report.
    Matsunaga T; Hirano H; Maenosono R; Tsutsumi T; Tsujino T; Yoshikawa Y; Takai T; Minami K; Uehara H; Komura K; Nomi H; Ibuki N; Inamoto T; Azuma H
    Transplant Proc; 2020; 52(6):1928-1930. PubMed ID: 32444119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D; Johansson S; Lindberg LO
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature.
    Kheradmand T; Anthony TL; Harland RC; Testa G; Hart J; Renz J; Te HS; Marino SR
    Hum Immunol; 2014 Jun; 75(6):578-83. PubMed ID: 24530823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical peritubular capillaritis in serial graft biopsies in cadaveric kidney transplant recipient with pre-transplant anti-HLA antibodies.
    Masutani K; Kitada H; Noguchi H; Tsuruya K; Katafuchi R; Tanaka M; Iida M
    Clin Transplant; 2009 Aug; 23 Suppl 20():34-8. PubMed ID: 19594594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive pre-transplant flow-panel reactive antibody detected after accelerated acute rejection with negative pre-transplant flow crossmatch.
    Miura M; Kubota KC; Itoh T; Ono T; Morita K; Watarai Y; Harada H; Hirano T; Nonomura K
    Clin Transplant; 2006; 20 Suppl 15():33-7. PubMed ID: 16848873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report.
    Thammanichanond D; Tammakorn C; Worawichawong S; Kantachuvesiri S
    Transplant Proc; 2020; 52(6):1931-1936. PubMed ID: 32444122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.
    Hirai T; Kohei N; Omoto K; Ishida H; Tanabe K
    Transpl Int; 2012 Sep; 25(9):925-34. PubMed ID: 22764746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veno-occlusive disease/sinusoidal obstruction syndrome associated with potential antibody-mediated rejection after pediatric living donor liver transplantation: a case report.
    Yamada N; Urahashi T; Ihara Y; Sanada Y; Wakiya T; Okada N; Mizuta K
    Transplant Proc; 2012 Apr; 44(3):810-3. PubMed ID: 22483502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry.
    Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R
    Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
    Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of second renal transplantation with acute antibody-mediated rejection complicated with BK virus nephropathy.
    Atsumi H; Asaka M; Kimura S; Imura J; Fujimoto K; Chikazawa Y; Nakagawa M; Okuyama H; Yamaya H; Moriyama M; Tanaka T; Suzuki K; Yokoyama H
    Clin Transplant; 2010 Jul; 24 Suppl 22():35-8. PubMed ID: 20590692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab induction therapy in highly sensitized kidney transplant recipients.
    Yin H; Wan H; Hu XP; Li XB; Wang W; Liu H; Ren L; Zhang XD
    Chin Med J (Engl); 2011 Jul; 124(13):1928-32. PubMed ID: 22088448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does MICA influence acute rejection in kidney transplantation?
    Kato M; Kinukawa T; Hattori R; Tsuji Y; Hirano A; Horie K; Tsuyuki M; Mizutani K
    Clin Transpl; 2006; ():389-93. PubMed ID: 18365394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.